Microfluidics-imaging platform detects cancer growth signaling in minute biopsy samples
Monday, November 1, 2010 - 17:00
in Biology & Nature
Inappropriate growth and survival signaling, which leads to the aberrant growth of cancer cells, is a driving force behind tumors. Much of current cancer research focuses on the kinase enzymes whose mutations are responsible for such disregulated signaling, and many successful molecularly targeted anti-cancer therapeutics are directed at inhibiting kinase activity.